The biotherapeutic market has grown and matured dramatically over recent years.
Future therapeutic successes will not be derived solely in North America or in Europe, but rather (based) on international cooperation with companies (working together) to accelerate the biodevelopment processes, said Kirstie Miller, president and CEO of Informa Life Sciences Group, in a press statement.
Current market conditions are perfect to introduce a publication that provides the international biotherapeutic community with the latest applications and technologies shaping the present and future development and manufacture of biotherapeutics, while providing a true voice of reason within this industry and around the world.
